FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and applies to a preparation for treatment of prostate diseases made in form of a suppository containing a complex of bioregulatory peptides of the prostate gland of cattle and a base additionally containining hyaluronidase, a hydrophilic base in form of polyethylene oxide (PEO) at the following ratio of components, wt.%: complex of bioregulatory peptides of the prostate gland 2.5, hyaluronidase 2.5, polyethylene oxide (PEO) the rest. The group of inventions also relates to a preparation for treatment of prostate diseases made in form of a suppository containing a complex of bioregulatory peptides of the prostate gland of cattle and a base additionally containing hyaluronidase, a surface-active substance (SAS) in form of polysorbate 80, a diphilic base in form of witepsol.
EFFECT: group of inventions provides a prostatotropic effect.
2 cl, 5 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE DISEASES (VERSIONS) | 2009 |
|
RU2430733C2 |
| METHOD FOR TREATING PROSTATIC DISEASES | 2005 |
|
RU2304979C2 |
| AGENT "VITAPROST" FOR PROSTATE GLAND DISEASE TREATMENT | 1996 |
|
RU2112504C1 |
| MEANS FOR TREATMENT OF CHRONIC PROSTATITIS | 2007 |
|
RU2342940C1 |
| RECTAL MEANS FOR TREATING CHRONIC PROSTATITIS | 1999 |
|
RU2160114C1 |
| AGENT FOR TREATMENT OF PROSTATE DISEASE | 2005 |
|
RU2278681C1 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES OF LOWER PART OF GENITOURINARY SYSTEM | 2010 |
|
RU2428173C1 |
| BIOLOGICALLY ACTIVE PHOSPHOLIPID-COMPRISING COMPLEX FOR TREATMENT OF PSORIASIS AND CHRONIC PROSTATITIS | 2003 |
|
RU2275205C2 |
| RECTAL AGENT | 1999 |
|
RU2152204C1 |
| MEDICAL PRODUCT AND MEDICINAL COMPOSITION FOR MANUFACTURING THEREOF | 2008 |
|
RU2372933C1 |
